Long and Short-term Metformin Consumption as a Potential Therapy to Prevent Complications of COVID-19

CONCLUSION: In this trial, metformin consumption had no effect on mortality and ICU admission rates in non-diabetic patients. However, metformin improved COVID-19 complications in diabetic patients who had been receiving metformin prior to COVID-19 infection, and it significantly lowered the intubation rates.PMID:37646067 | PMC:PMC10460805 | DOI:10.34172/apb.2023.066
Source: Adv Data - Category: Epidemiology Authors: Source Type: research